Dr. Hu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1021 Morehead Medical Drive
Levine Cancer Institute/Atrium Health
Charlotte, NC 28204Phone+1 980-442-2000- Is this information wrong?
Summary
- Lymphoma and apheresis attending at Levine Cancer Institute/Atrium Health. Board certified in Hematology, Medical Oncology, and Internal Medicine
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
Vanderbilt University Medical CenterResidency, Internal Medicine, 2011 - 2014
University of California San Francisco School of MedicineClass of 2011
Certifications & Licensure
NC State Medical License 2017 - 2025
TX State Medical License 2015 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Conquer Cancer Merit Award ASCO, Conquer Cancer Foundation, 2016
Clinical Trials
- Safety and Pharmacokinetics of Multiple Dose of YC-6 in Healthy Subjects Start of enrollment: 2016 Dec 01
- Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma Start of enrollment: 2019 Feb 19
Publications & Presentations
PubMed
- 1 citationsSafety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.Stephen Opat, Alessandra Tedeschi, Bei Hu, Kim M Linton, Pamela McKay, Sophie Leitch, Morton Coleman, Pier Luigi Zinzani, Jie Jin, Mingyuan Sun, Magdalena Sobieraj-Tea...> ;Blood Advances. 2023 Nov 28
- Genetic Predictors of Ibrutinib-related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia.Issam S Hamadeh, Jai N Patel, Ryan Jacobs, Hang Zeng, Jiaxian He, Bei Hu, Tamara Kay Moyo, Amy Soni, Steven Park, Ed Copelan, Belinda Avalos, Alicia Hamilton, Nury Ste...> ;Clinical Cancer Research. 2023 Dec 1
- 3 citationsRituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type.Donald C Moore, Amy Soni, Bei Hu, Elton T. Smith, Jonathan Levine, Tamara K. Moyo, Ryan Jacobs, Nilanjan Ghosh, Steven I. Park> ;British Journal of Haematology. 2021 Oct 12
- Join now to see all
Journal Articles
- De Novo CD5+ diffuse large B cell lymphoma: clinic characterististics and clinical outcomes in the Rituximab era2. Hu B, Nastoupil LJ, Westin JR, Logavi S, Thakral B, Fayad LE, Hagemeister G, Neelapu S, Samaniego F, Lee HJ, Wang ML, Fanale M, Fowler N, Oki Y, Leukemia and Lymphoma, 9/18/2019
- Standardizing opioid prescribing practices for cancer-related pain via a novel interactive documentation template at a public hospital3. Nusrat M, Parkes A, Kieser R, Hu B, Farhat D, Rieber A, Ma H, Journal of Oncology Practice, 6/21/2019
- A tale of two eras: the story of autologous stem cell transplantation with and without thiotepa for primary central nervous system lymphomaHu B, Biology of Blood and Marrow Transplantation, 5/2019
- Join now to see all
Press Mentions
Downregulation of SENP1 Suppresses LPS-Induced Macrophage Inflammation by Elevating Sp3 SUMOylation and Disturbing Sp3-NF-κB InteractionNovember 15th, 2020
High Use of Oncology Nurse Navigators Showed Similar Clinical Outcomes for White, Nonwhite Patients with DLBCLDecember 12th, 2019
Professional Memberships
- Member
- Member
Hospital Affiliations
Atrium Health's Carolinas Medical CenterCharlotte, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
